SYK and breast carcinoma: To better understand the apparent opposite functions of SYK depending on the cancer type (reviewed by [15,16]), we and other groups used quantitative phosphoproteomic approaches to identify novel SYK signaling effectors in breast cancer cells [17,18,19].